A potential novel combination therapy targeting survivin in renal cancer cells: Inhibition of survivin expression by topotecan and hexamethylene bisacetamide

Akinori Sato, Takako Asano, Keiichi Ito, Makoto Sumitomo, Tomohiko Asano, Masamichi Hayakawa

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'A potential novel combination therapy targeting survivin in renal cancer cells: Inhibition of survivin expression by topotecan and hexamethylene bisacetamide'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds